Nalbuphine HCl ER
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nalbuphine HCl ER, covering 2020-09-07 to 2020-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis [Phase 2, Phase 3]